For Patients: Clinical Trials
Publications
Careers
Contact Us
Toggle navigation
About INOVIO
Purpose, Mission and Values
Leadership
Partnerships
DNA Medicines Technology
Optimized Plasmid Design and Delivery
DNA Medicines Explained
The Promise of DNA Medicine
NEXT GEN DNA MEDICINE
DNA Medicines Pipeline
Investors & Media
Events & Presentations
Stock Information
News Releases
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder Services
FAQ
For Patients: Clinical Trials
Publications
Careers
Contact Us
About INOVIO
Purpose, Mission and Values
Leadership
Partnerships
DNA Medicines Technology
Optimized Plasmid Design and Delivery
DNA Medicines Explained
The Promise of DNA Medicine
NEXT GEN DNA MEDICINE
DNA Medicines Pipeline
Investors & Media
Events & Presentations
Stock Information
News Releases
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder Services
FAQ
For Patients: Clinical Trials
Publications
Careers
Contact Us
Press Releases
INOVIO to Present at Upcoming Scientific Conference
Posted on July 7, 2025
INOVIO to Present at Upcoming Scientific Conference
Posted on July 7, 2025
INOVIO Announces Pricing of $25 Million Public Offering
Posted on July 3, 2025
INOVIO Announces Pricing of $25 Million Public Offering
Posted on July 3, 2025
INOVIO Announces Proposed Public Offering
Posted on July 2, 2025
INOVIO Announces Proposed Public Offering
Posted on July 2, 2025
INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
Posted on June 9, 2025
INOVIO to Present at Upcoming Scientific and Investor Conferences
Posted on June 9, 2025
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted on June 9, 2025
INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
Posted on June 9, 2025
Page 1 of 16
1
2
3
4
5
...
10
...
»
Last »
© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.
